Christopher J. Tovey

Chief Operating Officer, GW PHARMACEUTICALS PLC.

Companies

Jazz PharmaceuticalsChief operating officer May 7, 2021 to Jul 7, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jazz Pharmaceuticals JAZZ14,663 shares²$3.0M at $207.05Jul 5, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 5, 2022Sold 1,177 shares at $160.00 of Jazz Pharmaceuticals²
Jul 5, 2022Sold 4,032 shares at $160.00 of Jazz Pharmaceuticals²
Jul 5, 2022Exercised options 4,032 shares at $0.02 of Jazz Pharmaceuticals²
May 5, 2022Shares withheld for tax 1,096 shares at $153.22 of Jazz Pharmaceuticals³
Mar 3, 2022Granted 7,820 shares of Jazz Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJazz Pharmaceuticals, Chief operating officer
2
SEC EDGARJazz Pharmaceuticals shares after the filing of Jul 5, 2022
3
SEC EDGARForm 4 filed May 9, 2022
4
SEC EDGARForm 4 filed Mar 9, 2022